|
Study
Defends Preventive Mastectomies
By
Linda A. Johnson, Associated Press Writer
Removing the
healthy breasts of women with genetic mutations that often trigger
breast cancer can save their lives, Dutch researchers found in
the strongest study yet to show that the controversial strategy
works.
In the study,
none of the women who chose to undergo preventive, or prophylactic,
mastectomies developed the often-deadly cancer. In a comparison
group of women who also had the mutant genes and opted only for
regular checkups, one-eighth got breast cancer and one woman died.
Scientists
had questioned whether the extreme approach really prevents breast
cancer because some breast tissue remains after surgery and the
dangerous mutant genes are in every cell in the body.
``We can say
to our patients that this method of prevention is nearly 100 percent
effective and that they can sleep without fear of getting breast
cancer,'' said Dr. Jan Klijn, chairman of the Rotterdam Family
Cancer Clinic, part of Erasmus University Medical Center, where
the research was done.
Other experts,
however, cautioned that the women, many in their 20s and 30s,
were followed for only three years on average.
``My guess
is that some small number of women might'' later develop breast
cancer despite the mastectomy, said Dr. Marvin Schwalb, director
of the Center for Human and Molecular Genetics at the University
of Medicine and Dentistry of New Jersey.
The research
was reported in Thursday's New England Journal of Medicine.
From 1992
on, Klijn and colleagues studied 139 women after they were determined
by DNA testing to have a dangerous mutation on either of the breast
cancer susceptibility genes, BRCA1 and BRCA2. The mutations carry
a lifetime breast cancer risk of up to 85 percent.
More than
half of the women - 76 - chose to have a prophylactic mastectomy,
with most later having breast reconstruction.
The 63 other
women chose regular follow-up: annual mammograms or MRI screenings,
examination by a doctor every six months and monthly breast self-exams.
Eight developed breast cancer during the study, with half detecting
it themselves between screenings.
``It's a really
fine study,'' said Dr. Lynn Hartmann, a cancer specialist at the
Mayo Clinic in Rochester, Minn. ``Three or four years ago, women
were doing this with no proof at all that it worked.''
Hartmann and
colleagues reported in 1999 that prophylactic mastectomies cut
the risk of developing breast cancer at least 90 percent.
They reviewed
medical records of 639 women who underwent the procedure from
1960 through 1993. But such retrospective studies are valued less
by researchers than prospective ones, where each patient group
gets exactly the same care.
The women
in the Mayo Clinic study sought prophylactic mastectomies because
they had relatives with breast cancer and feared getting it. DNA
testing for the mutant genes was not possible at the time.
Subsequent
testing found 16 of them had the mutant genes, but none have developed
breast cancer in 12 years of follow-up, Hartmann said.
In an editorial
in the journal, Dr. Barbara L. Weber of the University of Pennsylvania
and Dr. Andrea Eisen of McMaster University in Canada said that
the studies by Klijn and Hartmann suggest that prophylactic mastectomy,
while extreme, is the most effective prevention strategy.
They urged
support for research to find better breast cancer screening methods
and medications that can prevent the disease.
On the Net:
http://www.nejm.com
Facing Our
Risk of Cancer Empowered (support group): http://www.facingourrisk.org/
National Cancer
Institute
http://www.cancernet.nci.nih.gov/index.html
Reference
Source 102
For more information on how to prevent other diseases, use
PreventDisease.com's "Quick
Prevention Resources".
|